BrightInsight

BrightInsight

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $166M

Overview

BrightInsight is the leading global regulated digital health platform, serving top biopharma and medtech companies. Its cloud-based platform offers pre-built, compliant functionality to build and scale digital health products like drug companion apps and SaMD, reducing development time by 6-24 months. The company has demonstrated success with major partners like Sanofi and CSL Behring, driving improved patient adherence, engagement, and real-world data capture. BrightInsight operates as a private, revenue-generating platform company in a high-growth sector.

ImmunologyRare DiseasesMultiple across 11 therapy areas

Technology Platform

Cloud-based regulated platform for building, launching, and scaling digital health solutions (SaMD, companion apps, connected devices). Includes pre-built compliant features, a real-time analytics dashboard engine, and global scalability with built-in security, privacy, and regulatory controls.

Funding History

3
Total raised:$166M
Series C$101M
Series B$40M
Series A$25M

Opportunities

The massive and growing demand from biopharma and medtech companies for compliant digital health infrastructure presents a vast market opportunity.
Expansion of existing partnerships and entry into new therapeutic areas and geographic regions offer clear growth paths.
Leveraging the real-world data aggregated on its platform to provide advanced analytics and AI-driven insights represents a significant future revenue stream.

Risk Factors

Revenue concentration risk with a reliance on a few major biopharma partners.
Intensifying competition from large cloud hyperscalers and other digital health platform startups.
Execution and regulatory risk associated with maintaining a globally compliant platform amidst evolving standards and cybersecurity threats.

Competitive Landscape

BrightInsight operates in a competitive but specialized market. It faces potential competition from large cloud infrastructure providers (AWS, Google Cloud, Microsoft Azure) offering healthcare cloud services, as well as from other digital health platform and SaMD enablement companies. Its key competitive advantages are its first-mover status, deep focus on life sciences regulatory compliance, proven deployment scale with top clients, and a pre-built functionality library that significantly accelerates time-to-market.